SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 75 filers reported holding SERES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $51,000 | -96.2% | 2,503 | -94.9% | 0.00% | -100.0% |
Q4 2020 | $1,327,000 | -12.4% | 49,546 | -7.7% | 0.00% | 0.0% |
Q3 2020 | $1,515,000 | +39.1% | 53,707 | -72.9% | 0.00% | 0.0% |
Q2 2020 | $1,089,000 | +84.9% | 197,968 | +6.2% | 0.00% | 0.0% |
Q1 2020 | $589,000 | +3581.2% | 186,338 | +3947.3% | 0.00% | – |
Q4 2019 | $16,000 | +23.1% | 4,604 | +43.9% | 0.00% | – |
Q3 2019 | $13,000 | +116.7% | 3,199 | +85.7% | 0.00% | – |
Q2 2019 | $6,000 | +500.0% | 1,723 | +538.1% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 270 | +91.5% | 0.00% | – |
Q3 2018 | $1,000 | -97.7% | 141 | -97.2% | 0.00% | – |
Q2 2018 | $43,000 | +22.9% | 4,974 | +3.0% | 0.00% | – |
Q1 2018 | $35,000 | -28.6% | 4,829 | 0.0% | 0.00% | – |
Q4 2017 | $49,000 | -86.1% | 4,829 | -78.0% | 0.00% | – |
Q3 2017 | $353,000 | +63.4% | 21,979 | +14.8% | 0.00% | – |
Q2 2017 | $216,000 | 0.0% | 19,144 | 0.0% | 0.00% | – |
Q1 2017 | $216,000 | +45.0% | 19,144 | +28.4% | 0.00% | – |
Q4 2016 | $149,000 | +1762.5% | 14,915 | +2385.8% | 0.00% | – |
Q3 2016 | $8,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
Geduld E E | 15,000 | $149,000 | 0.08% |
Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |